Richard M. Turner

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

The Clinical Pharmacogenetics Implementation Consortium Guideline for <i>SLCO1B1</i>, <i>ABCG2</i>, and <i>CYP2C9</i> genotypes and Statin‐Associated Musculoskeletal Symptoms

Rhonda M. Cooper‐DeHoff, Mikko Niemi, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2022 · 296 citations · Full text

Continuous flow reaction monitoring using an on‐line miniature mass spectrometer

Duncan L. Browne, Steven L. Wright, Benjamin J. Deadman et al. · Rapid Communications in Mass Spectrometry · 2012 · 130 citations · Full text

Flow Chemistry Meets Advanced Functional Materials

R. M. Myers, Daniel E. Fitzpatrick, Richard M. Turner et al. · Chemistry - A European Journal · 2014 · 120 citations

A Self-Organizing Chemical Assembly Line

Airton G. Salles, Salvatore Zarra, Richard M. Turner et al. · Journal of the American Chemical Society · 2013 · 107 citations

Combinatorial Chemistry, Engineering, Chemical Transformation +16